Walvax Biotechnology Co Ltd
Walvax Biotechnology Co., Ltd., engages in the research and development, manufacture, and distribution of vaccines in China and internationally. Its vaccine portfolio includes recombinant human papillomavirus bivalent, 13-valent pneumococcal polysaccharide conjugate, 23-valent pneumococcal polysaccharide, group ACYW135 meningococcal polysaccharide, group A and C meningococcal polysaccharide, group A and group C meningococcal conjugate, and haemophilus influenzae type b conjugate vaccines, as well as diphtheria, tetanus and acellular pertussis combined vaccine. The company was founded in 2001 and is headquartered in Kunming, China.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of 300142-SZ would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (2010) — listing | $25,987 1.1× | $38,387 1.1× |
| Year 6 (2015) | $11,981 0.7× | $17,676 0.7× |
| Year 11 (2020) | $5,447 0.6× | $8,067 0.6× |
| Year 16 (2025) | $2,218 1.1× | $3,314 1.1× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Yunnan University, People's Republic of China
Popular scenarios with 300142
For illustration only — not investment advice. Past performance is not indicative of future results.